The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis.
Ontology highlight
ABSTRACT: Nucleotide-binding domain and leucine-rich repeat (NLR) proteins are a diverse family of pattern recognition receptors that are essential mediators of inflammation and host defense in the gastrointestinal system. Recent studies have identified a subgroup of inflammasome forming NLRs that modulate the mucosal immune response during inflammatory bowel disease (IBD) and colitis associated tumorigenesis. To better elucidate the contribution of NLR family members in IBD and cancer, we conducted a retrospective analysis of gene expression metadata from human patients. These data revealed that NLRP1, an inflammasome forming NLR, was significantly dysregulated in IBD and colon cancer. To better characterize the function of NLRP1 in disease pathogenesis, we used Nlrp1b(-/-) mice in colitis and coli
SUBMITTER: Williams TM
PROVIDER: S-EPMC4369420 | biostudies-literature | 2015 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA